|
Table of Contents 1. Analyst View
2. Research Methodology
3. DNA Vaccine - An Introduction
4. Drivers & Challenges
4.1 Drivers
4.1.1 Increasing Investment
4.1.2 Advantages of DNA Vaccines over Traditional Vaccines
4.1.3 Dramatic Increase in Chronic Disorders
4.1.4 Strong DNA Vaccine Pipeline
4.1.5 Technological Advancements
4.2 Challenges
4.2.1 Uncertainty in Regulatory System
4.2.2 Lack of Awareness in Developing Countries
4.2.3 Development Limited to Plasmid Vectors
5. DNA Vaccine Market Overview
6. DNA Vaccines Market by Geography
6.1 North America
6.2 Europe
6.3 Asia Pacific
7. DNA Vaccine Market by Type
7.1 Recombinant Protein Vaccines
7.1.1 By Geography (North America, Europe, Asia Pacific)
7.2 Genetic Vaccines
7.2.1 By Geography (North America, Europe, Asia-Pacific)
8. DNA Vaccines Market by End User
8.1 Human
8.2 Animal
9. DNA Vaccines Market by Therapeutic Indication
9.1 Infectious & Vector Borne Diseases
9.2 Cancer
10. Pipeline Analysis
11. Trends
11.1 Increasing Focus on Genetic Vaccine Development
11.2 Expanding Applications Increasing Popularity of DNA Vaccines
11.3 Partnerships Enhancing Genetic Vaccines Development
12. Company Profiles
12.1 Novartis International AG
12.2 Merck & Co., Inc
12.3 GlaxoSmithKline plc.
12.4 Sanofi
12.5 Zoetis
12.6 Green Cross Corporation
12.7 Inovio Pharmaceuticals, Inc.,
12.8 Bharat Biotech
12.9 Protein Sciences Corporation
12.10 Indian Immunologicals Ltd.
12.11 Serum Institute of India Pvt. Ltd
13. Recommendations
List of Figures: Figure 5-1: Share of DNA Vaccines in Global Vaccine Market (%), 2016
Figure 5-2: Share of DNA Vaccines in Global Vaccine Market (%), 2022
Figure 5-3: Global - DNA Vaccine Market (Billion US$), 2016-2022
Figure 6-1: Global - DNA Vaccine Market by Geography (%), 2016
Figure 6-2: Global - DNA Vaccine Market by Geography (%), 2022
Figure 6-3: North America - DNA Vaccine Market (Billion US$), 2016 & 2022
Figure 6-4: Europe - DNA Vaccine Market (Billion US$), 2016 & 2022
Figure 6-5: Asia Pacific - DNA Vaccine Market (Billion US$), 2016 & 2022
Figure 7-1: Global - DNA Vaccine Market by Type (%), 2016
Figure 7-2: Global - DNA Vaccine Market by Type (%), 2022
Figure 7-3: Global - Recombinant Protein Vaccines Market (Billion US$), 2016 & 2022
Figure 7-4: Global - Recombinant Protein Vaccines Market by Geography (%), 2016
Figure 7-5: Global - Recombinant Protein Vaccines Market by Geography (%), 2022
Figure 7-6: North America - Recombinant Protein Vaccines Market (Billion US$), 2016 & 2022
Figure 7-7: Europe - Recombinant Protein Vaccines Market (Billion US$), 2016 & 2022
Figure 7-8: Asia Pacific - Recombinant Protein Vaccines Market (Billion US$), 2016 & 2022
Figure 7-9: Global - Genetic Vaccines Market (Billion US$), 2016 & 2022
Figure 7-10: Global - Genetic Vaccines Market by Geography (%), 2016
Figure 7-11: Global - Genetic Vaccines Market by Geography (%), 2022
Figure 7-12: North America - Genetic Vaccines Market (Billion US$), 2016 & 2022
Figure 7-13: Europe - Genetic Vaccines Market (Billion US$), 2016 & 2022
Figure 7-14: Asia Pacific - Genetic Vaccines Market (Billion US$), 2016 & 2022
Figure 8-1: Global - DNA Vaccine Market by End User (%), 2016
Figure 8-2: Global - DNA Vaccine Market by End User (%), 2022
Figure 8-3: Global - Human DNA Vaccine Market (Billion US$), 2016 & 2022
Figure 8-4: Global - Animal DNA Vaccine Market (Billion US$), 2016 & 2022
Figure 9-1: Global - DNA Vaccine Market by Therapeutic Segment (%), 2016
Figure 9-2: Global - DNA Vaccine Market by Therapeutic Segment (%), 2022
Figure 9-3: Global - DNA Vaccine Market for Infectious & Vector Borne Diseases (Billion US$), 2016 & 2022
Figure 9-4: Global - DNA Vaccine Market for Cancer (Billion US$), 2016 & 2022
Figure 10-1: Global - DNA Vaccine Pipeline Analysis by Phase (%), 2016
Figure 10-2: Global - DNA Vaccine Pipeline by Therapeutic Indication (%), 2016
Figure 10-3: Global - DNA Vaccine Pipeline by Vaccine Type (%), 2016
Figure 10-4: Global - DNA Vaccine Pipeline by Application (%), 2016
Figure 12-1: Novartis - Break-up of Revenue by Product Category (%), 2015
Figure 12-2: Novartis - Break-up of Revenue by Geographical Region (%), 2015
Figure 12-3: Merck & Co. Inc - Break-up of Revenue by Product Category (%), 2015
Figure 12-4: Merck & Co. Inc - Break-up of Revenue by Geographical Region (%), 2015
Figure 12-5: GlaxoSmithKline – Break-up of Revenue by Product Category (%), 2015
Figure 12-6: GlaxoSmithKline - Break-up of Revenue by Geographical Region (%), 2015
Figure 12-7: Sanofi - Break-up of Revenue by Product Category (%), 2015
Figure 12-8: Sanofi - Break-up of Revenue by Geographical Region (%), 2015
Figure 12-9: Zoetis - Break-up of Revenue by Product Category (%), 2015
Figure 12-10: Zoetis - Break-up of Revenue by Geographical Region (%), 2015
Figure 12-11: Green Cross Corporation - Break-up of Revenue by Geographical Region (%), 2015
List of Tables: Table 10-1: Global - DNA Vaccines Pipeline
Table 12-1: Novartis International AG - Product Portfolio
Table 12-2: Novartis International AG - Pipeline Analysis
Table 12-3: Novartis - Key Financials (Million US$), 2013-2015
Table 12-4: Merck & Co. Inc - Product Portfolio
Table 12-5: Merck & Co. Inc - Key Financials (Million US$), 2013-2015
Table 12-6: GlaxoSmithKline - Product Portfolio
Table 12-7: GlaxoSmithKline - Key Financials (Million US$), 2013-2015
Table 12-8: Sanofi - Product Portfolio
Table 12-9: Sanofi - Pipeline Analysis
Table 12-10: Sanofi - Key Financials (Million US$), 2013-2015
Table 12-11: Zoetis - Product Portfolio
Table 12-12: Zoetis - Key Financials (Million US$), 2013-2015
Table 12-13: Green Cross Corporation - Product Portfolio
Table 12-14: Green Cross Corporation - Key Financials (Million US$), 2013-2015
Table 12-15: Inovio Pharmaceuticals - Key Financials (Million US$), 2013-2015
Table 12-16: Inovio Pharmaceuticals - Pipeline Analysis
Table 12-17: Bharat Biotech - Product Portfolio
Table 12-18: Protein Sciences Corporation - Product Portfolio
Table 12-19: Protein Sciences Corporation - Pipeline Analysis
Table 12-20: Indian Immunologicals Ltd. - Product Portfolio
Table 12-21: Serum Institute of India Pvt. Ltd. - Product Portfolio
Table 12-22: Serum Institute of India Ltd. - Pipeline Analysis
|
현재위치 : 
